Navigation Links
Breast Cancer Drugs May Fight Cervical Cancer, Too
Date:11/9/2009

Study in mice reports success with drugs that inhibit estrogen,,

MONDAY, Nov. 9 (HealthDay News) -- Two drugs used to treat breast cancer and osteoporosis eliminated cervical cancer in mice, according to a new study.

The drugs also cleared precancerous growths in the cervix and vagina, and prevented the onset of cancer in mice with precancerous lesions.

The breast cancer drug fulvestrant and the breast cancer/osteoporosis drug raloxifene were given to mice genetically engineered to carry human papillomavirus (HPV) 16, which is strongly associated with cervical cancer. Both drugs prevent estrogen from working in cells. Fulvestrant is marketed for women as Faslodex, and raloxifene is marketed as Evista.

The study appears in this week's issue of the Proceedings of the National Academy of Sciences.

"We have begun to test whether the drugs are as effective in treating cervical cancer in human cells as they are in our mice," senior study author Dr. Paul F. Lambert, an oncology professor at the University of Wisconsin School of Medicine and Public Health, said in a university news release.

If the lab studies, expected to take one or two years, are successful, they could be followed quickly by clinical trials, the researchers said.

Nearly all cervical cancers test positive for HPV 16, Lambert said, but not all women infected with HPV get cervical cancer, which has led researchers to examine other factors.

"Since the cervix and other female reproductive organs are so responsive to estrogen, our lab and others began to focus on that hormone," he explained.

Fulvestrant and raloxifene block a receptor (estrogen receptor alpha) that mediates estrogen function in cells.

"We can't be sure how the science will translate from animals to humans, but we have faith in our mouse model," Lambert said. "There are many similarities in how cervical cancer develops and manif
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Survival differences by race most apparent in advanced stages of breast cancer
2. MRI finds breast cancer before it becomes dangerous
3. Pathway links inflammation, angiogenesis and breast cancer
4. Drop in breast cancer incidence linked to hormone use, not mammograms
5. Breast cancer prevention practices vary across Canada
6. Eating junk food whilst pregnant and breastfeeding may lead to obese offspring
7. Acrylamide Wont Raise Breast Cancer Risk
8. New link between estrogen and breast cancer
9. Hypnosis Eases Pain of Breast Cancer Surgery
10. Discovery suggests location of genes for breast density, a strong risk factor for breast cancer
11. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... ... August 31, 2015 , ... ... airway management device that could effectively deliver oxygen with a lower risk of ... a better way, I invented the Adam Device." , The Adam Device offers ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... professional association for physicians and allied health professionals dedicated to using lifestyle ... announced today the establishment of the Lifestyle Medicine Lifetime Achievement and Trailblazer ...
(Date:8/31/2015)... ... August 31, 2015 , ... MeYou Health ®, a ... mobile walking app, Walkadoo , by including an in-app step tracker. , ... to each person’s walking habits. Rather than broadly assign every Walkadoo member 10,000 steps ...
(Date:8/31/2015)... ... , ... There’s big news for ZendyHealth , a Los Angeles-based startup ... driven health plans (CDHPs) are a growing phenomenon, and ZendyHealth has brought on two ... and another to answer customers’ questions directly. , John Young, CEO of Consumerdriven, LLC ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... the Talent Management Division , a department devoted to helping organizations identify ... Talent management goes beyond selection, and The Brooks Group believes in offering a ...
Breaking Medicine News(10 mins):Health News:InventHelp® Client's Invents Medical Device to Restore Respiratory Function (BGF-905) 2Health News:Nominations Sought for Awards Recognizing Exemplary Contribution to the Field of Lifestyle Medicine 2Health News:Nominations Sought for Awards Recognizing Exemplary Contribution to the Field of Lifestyle Medicine 3Health News:Walkadoo™ Walking Program Now Includes In-app Step Tracker 2Health News:ZendyHealth Adds Two Prestigious Consumer Driven Health Plan (CDHP) Experts 2Health News:ZendyHealth Adds Two Prestigious Consumer Driven Health Plan (CDHP) Experts 3Health News:The Brooks Group Introduces Talent Management Division 2Health News:The Brooks Group Introduces Talent Management Division 3
... VOORHEES, N.J. , Feb. 1 ... particularly in the adult population. To optimally manage this ... identify characteristics of high-risk disease, utilize best strategies for ... role of post-remission hematopoietic stem cell transplantation in ALL ...
... , Feb. 10 Event With Celebrity Panel To Discuss Findings ... increased scrutiny of the fashion industry and its use of ultrathin models ... that the fashion industry is at least partially responsible for "girls, obsession ... Girl Scouts of the USA . , The nationwide survey, which ...
... have shown positron emission tomography,s (PET) value as a ... pediatric conditions. In a study published in the February ... (JNM), researchers at the Children,s Hospital of Philadelphia (CHOP) ... may provide clinicians with new formulasspecific to pediatricsto calculate ...
... antibiotics gave physicians seemingly miraculous weapons against infectious ... syphilis and tuberculosis were suddenly at hand. Moreover, ... were versatile enough to knock out a wide ... have a fundamental limitation: They,re useless against viruses, ...
... today announced the first annual Translational Regenerative Medicine ... the Benton Convention Center in Winston-Salem. The ... medicine and health care innovation through the sharing ... and business models. Reflecting the global scope of ...
... ... and Better Decision Making , ... (PRWEB) February 1, 2010 -- BridgeGate International, a leading ... a strategic partnership agreement with Information Builders, a leader in business intelligence (BI) ...
Cached Medicine News:Health News:Select Topics in ALL: Molecular Characterization, Approaches to CNS Disease, and Post-remission Transplantation 2Health News:Nationwide Study Finds That Teenage Girls Have Mixed Feelings About the Fashion Industry 2Health News:Nationwide Study Finds That Teenage Girls Have Mixed Feelings About the Fashion Industry 3Health News:Nationwide Study Finds That Teenage Girls Have Mixed Feelings About the Fashion Industry 4Health News:Child-specific doses for pediatric PET patients 2Health News:Compound found that targets wide range of viruses 2Health News:Translational Regenerative Medicine Forum sets stage for accelerating therapies to patients 2Health News:BridgeGate and Information Builders form Strategic Partnership to Extend Integration Capability for Healthcare and Government Markets 2Health News:BridgeGate and Information Builders form Strategic Partnership to Extend Integration Capability for Healthcare and Government Markets 3
(Date:8/28/2015)... -- Research and Markets ( ... "Investigation Report on China,s Pranoprofen Market, 2010-2019" ... discovered by Welfide (Mitsubishi Tanabe Pharma Corporation formerly ... inflammatory drug, pranoprofen was later developed into eye ... trade name of pranopulin for the treatment of ...
(Date:8/28/2015)... Aug. 28, 2015 Research ... of the "Investigation Report on China,s Tobramycin Market, ... is a traditional antibiotic whose eye drop and ointment ... of potential infection or inflammation caused by eye infection. ... are able to produce tobramycin, among which the ...
(Date:8/28/2015)... Aug. 28, 2015 ... the addition of the "Investigation Report on ... offering. Developed by AstraZeneca plc, quetiapine ... important drug for the treatment of schizophrenia. Approved ... was listed in the Catalogue of Drugs for ...
Breaking Medicine Technology:Investigation Report on China's Pranoprofen Market, 2010-2019 2Investigation Report on China's Tobramycin Market, 2015-2019 2China Quetiapine Market Investigation Report 2010-2019 2
... 2011 BioDelivery Sciences International, Inc. (Nasdaq: ... a confirmatory pharmacokinetic study of a formulation of ... (BEMA) drug delivery technology.   (Logo: ... will be used to select the final doses ...
... 10, 2011 HeartWare International, Inc. (NASDAQ: ... less invasive, miniaturized circulatory support technologies that are revolutionizing ... CEO Doug Godshall is scheduled to present at the ... p.m. EST on Wednesday, November 16, 2011.  The conference ...
Cached Medicine Technology:BioDelivery Sciences Initiates Confirmatory Pharmacokinetic Study of BEMA Buprenorphine/Naloxone Compared to Suboxone 2BioDelivery Sciences Initiates Confirmatory Pharmacokinetic Study of BEMA Buprenorphine/Naloxone Compared to Suboxone 3BioDelivery Sciences Initiates Confirmatory Pharmacokinetic Study of BEMA Buprenorphine/Naloxone Compared to Suboxone 4HeartWare to Present at the Lazard Capital Markets 8th Annual Healthcare Conference 2
... whistle tip suction catheter is packed ... suction catheter, pop-up solution cup and ... in order of use with cuffed ... tissue envelope. Available in sizes 12 ...
... suction catheter included with each kit maximizes ... ,All Portex® No Pour Pak® II suction ... ,No Pour Pak® II suction catheter kits ... protecting the patient and clinician from exposure ...
... of suction products in the U.S. We ... assure that their quality meets or exceeds ... directly support our full line of products ... Poole Tip Suction handles, suction canisters, liners ...
Suction Catheter Trays with Sterile Water...
Medicine Products: